Descriptor
| Pharmacy | 3 |
| Drug Therapy | 2 |
| Mental Retardation | 2 |
| Patients | 2 |
| Age | 1 |
| Behavior Modification | 1 |
| Developmental Disabilities | 1 |
| Drug Use | 1 |
| Epilepsy | 1 |
| Incidence | 1 |
| Longitudinal Studies | 1 |
| More ▼ | |
Source
| Journal of Intellectual… | 3 |
Author
| Arvio, M. | 1 |
| Engelman, L. | 1 |
| Fernandez, G. | 1 |
| Haw, C. | 1 |
| Lott, I. T. | 1 |
| McGregor, M. | 1 |
| Plon, L. | 1 |
| Sandman, C. | 1 |
| Sillanpaa, M. | 1 |
| Stubbs, J. | 1 |
| Touchette, P. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 3 |
| Numerical/Quantitative Data | 1 |
| Reports - Descriptive | 1 |
| Reports - Evaluative | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkArvio, M.; Sillanpaa, M. – Journal of Intellectual Disability Research, 2005
To study the effectiveness of topiramate (TPM) in refractory epilepsy in patients who have intellectual disability (ID). A representative population sample of 57 patients with ID (age range 261, mean 32.8) was administered add-on TPM for drug-refractory epilepsy. Results Seizure freedom for at least for 6months was attained by 10 (17%), and…
Descriptors: Patients, Seizures, Epilepsy, Incidence
Lott, I. T.; McGregor, M.; Engelman, L.; Touchette, P.; Tournay, A.; Sandman, C.; Fernandez, G.; Plon, L.; Walsh, D. – Journal of Intellectual Disability Research, 2004
Little is known about longitudinal prescribing practices for psychoactive medications for individuals with intellectual disabilities and developmental disabilities (IDDD) who are living in community settings. Computerized pharmacy records were accessed for 2344 community-based individuals with IDDD for whom a total of 3421 prescriptions were…
Descriptors: Drug Therapy, Developmental Disabilities, Behavior Modification, Mental Retardation
Haw, C.; Stubbs, J. – Journal of Intellectual Disability Research, 2005
Background: The term "off-label prescribing" refers to the use of a drug outside the terms of its Marketing Authorisation, including prescribing for an unlicensed indication. There have been few reports about off-label prescribing in psychiatry. The aims of the study were to determine the frequency of off-label prescribing of psychotropics for…
Descriptors: Psychiatric Hospitals, Psychiatry, Patients, Mental Disorders
